Leonteq Securities AG’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-80,000
Closed -$197K 1333
2026
Q1
$197K Buy
80,000
+59,000
+281% +$197K 0.01% 602
2025
Q4
$83.6K Buy
+21,000
New +$92.9K ﹤0.01% 839
2021
Q3
Sell
-1,612
Closed -$135K 1174
2021
Q2
$135K Hold
1,612
0.01% 654
2021
Q1
$78.1K Sell
1,612
-2,387
-60% -$129K ﹤0.01% 724
2020
Q4
$189K Buy
+3,999
New +$157K 0.01% 572

Other funds holding NBP

Leonteq Securities AG's NBP Position: Q2 2026 in Review

Leonteq Securities AG sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026, closing a stake of 80,000 shares — an estimated $197K sold.

Leonteq Securities AG first reported a position in NBP in Q4 2020 and held it in 5 quarters. The position peaked at $197K in Q1 2026. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

  • Leonteq Securities AG reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 80,000 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $197K.
  • Leonteq Securities AG first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 5 quarters.
  • Leonteq Securities AG's NovaBridge Biosciences American Depositary Shares position peaked at $197K in Q1 2026.
  • 49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.